Inbrija and Fluid retention - a phase IV clinical study of FDA data
Fluid retention is reported only by a few people who take Inbrija.
The phase IV clinical study analyzes which people take Inbrija and have Fluid retention. It is created by eHealthMe based on reports of 6,065 people who have side effects while taking Inbrija from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
6,065 people reported to have side effects when taking Inbrija.
Among them, 2 people (0.03%) have Fluid retention.
What is Inbrija?
Inbrija has active ingredients of levodopa. eHealthMe is studying from 6,066 Inbrija users for its effectiveness, alternative drugs and more.
What is Fluid retention?
Fluid retention (an abnormal accumulation of fluid in the blood) is found to be associated with 3,044 drugs and 2,223 conditions by eHealthMe.
Number of Inbrija and Fluid retention reports submitted per year:
Gender of people who have Fluid retention when taking Inbrija *:
- female: 50 %
- male: 50 %
Age of people who have Fluid retention when taking Inbrija *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 100 %
Common drugs people take besides Inbrija *:
- Wellbutrin: 1 person, 50.00%
- Vitamin D: 1 person, 50.00%
- Vitamin B12: 1 person, 50.00%
- Prozac: 1 person, 50.00%
- Carbidopa And Levodopa: 1 person, 50.00%
- Calcium: 1 person, 50.00%
Common conditions people have *:
- Parkinson's Disease: 2 people, 100.00%
- On And Off Phenomenon: 1 person, 50.00%
* Approximation only. Some reports may have incomplete information.
Do you take Inbrija and have Fluid retention?Check whether Fluid retention is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Fluid retention and when was it recovered:
Expand to all the drugs that have ingredients of levodopa:
Alternative drugs to, pros and cons of Inbrija:
- Inbrija (6,066 reports)
Common Inbrija side effects:
- Dizziness: 230 reports
- Dyskinesia (abnormality or impairment of voluntary movement): 302 reports
- Insomnia (sleeplessness): 108 reports
Browse all side effects of Inbrija:a b c d e f g h i j k l m n o p q r s t u v w x y z
Fluid retention treatments and more:
- Fluid retention (71,317 reports)
COVID vaccines that are related to Fluid retention:
- Fluid retention in Moderna COVID Vaccine
- Fluid retention in Pfizer BioNTech Covid Vaccine
- Fluid retention in Johnson and Johnson Covid Vaccine
Common drugs associated with Fluid retention:
All the drugs that are associated with Fluid retention:
- Fluid retention (3,044 drugs)
Common conditions associated with Fluid retention:
All the conditions that are associated with Fluid retention:
- Fluid retention (2,223 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on levodopa (the active ingredients of Inbrija) and Inbrija (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Flecainide Acetate and Aortic Stenosis - a second ago
- Monopril and Pulmonary Valve Incompetence - 4 seconds ago
- Zyprexa and Psychosis - 6 seconds ago
- Nuedexta and Speech Impairment (Adult) - 9 seconds ago
- Enbrel and Methotrexate drug interaction - 11 seconds ago
- Hydroxyzine and Myoclonus - 19 seconds ago
- Methotrexate and Temporomandibular Joint Syndrome - 21 seconds ago
- Reglan and Haemarthrosis - 26 seconds ago
- Synthroid and Swollen Tongue - 36 seconds ago
- Novolog vs. Victoza - 40 seconds ago